Publications

Found 13 results
Author Title [ Type(Desc)] Year
Filters: Keyword is Mice  [Clear All Filters]
Journal Article
Kossatz S, Carney B, Schweitzer M, Carlucci G, Miloushev VZ, Maachani UB, Rajappa P, Keshari KR, Pisapia D, Weber WA et al..  2017.  Biomarker-Based PET Imaging of Diffuse Intrinsic Pontine Glioma in Mouse Models.. Cancer Res. 77(8):2112-2123.
Kelm-Nelson CA, Brauer AFL, Barth KJ, Lake JM, Sinnen MLK, Stehula FJ, Muslu C, Marongiu R, Kaplitt MG, Ciucci MR.  2018.  Characterization of early-onset motor deficits in the Pink1-/- mouse model of Parkinson disease.. Brain Res. 1680:1-12.
Ghosh HS, Cisse B, Bunin A, Lewis KL, Reizis B.  2010.  Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells.. Immunity. 33(6):905-16.
Marongiu R, Arango-Lievano M, Francardo V, Morgenstern P, Zhang X, M Cenci A, Svenningsson P, Greengard P, Kaplitt MG.  2016.  Gene therapy blockade of dorsal striatal p11 improves motor function and dyskinesia in parkinsonian mice.. Proc Natl Acad Sci U S A. 113(5):1423-8.
Rajappa P, Cobb WS, Vartanian E, Huang Y, Daly L, Hoffman C, Zhang J, Shen B, Yanowitch R, Garg K et al..  2017.  Malignant Astrocytic Tumor Progression Potentiated by JAK-mediated Recruitment of Myeloid Cells.. Clin Cancer Res. 23(12):3109-3119.
Wang M, Kommidi H, Tosi U, Guo H, Zhou Z, Schweitzer ME, Wu LY, Singh R, Hou S, Law B et al..  2017.  A Murine Model for Quantitative, Real-Time Evaluation of Convection-Enhanced Delivery (RT-CED) Using an [F]-Positron Emitting, Fluorescent Derivative of Dasatinib.. Mol Cancer Ther. 16(12):2902-2912.
Schintu N, Zhang X, Alvarsson A, Marongiu R, Kaplitt MG, Greengard P, Svenningsson P.  2016.  p11 modulates L-DOPA therapeutic effects and dyskinesia via distinct cell types in experimental Parkinsonism.. Proc Natl Acad Sci U S A. 113(5):1429-34.
Jannetti SA, Carlucci G, Carney B, Kossatz S, Shenker L, Carter LM, Salinas B, Brand C, Sadique A, Donabedian PL et al..  2018.  PARP-1-Targeted Radiotherapy in Mouse Models of Glioblastoma.. J Nucl Med. 59(8):1225-1233.
Schweitzer JS, Song B, Herrington TM, Park T-Y, Lee N, Ko S, Jeon J, Cha Y, Kim K, Li Q et al..  2020.  Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease.. N Engl J Med. 382(20):1926-1932.
Martin B, Garman T, Laramee M, Wang A, Zhang X, Beck E, Wilson K, Klumpp-Thomas C, McKnight C, Xu X et al..  2023.  Preclinical validation of a novel therapeutic strategy for choroid plexus carcinoma. J Control Release. 357:580-590.
Huang Y, Rajappa P, Hu W, Hoffman C, Cisse B, Kim J-H, Gorge E, Yanowitch R, Cope W, Vartanian E et al..  2017.  A proangiogenic signaling axis in myeloid cells promotes malignant progression of glioma.. J Clin Invest. 127(5):1826-1838.
Tosi U, Kommidi H, Bellat V, Marnell CS, Guo H, Adeuyan O, Schweitzer ME, Chen N, Su T, Zhang G et al..  2019.  Real-Time, in Vivo Correlation of Molecular Structure with Drug Distribution in the Brain Striatum Following Convection Enhanced Delivery.. ACS Chem Neurosci. 10(5):2287-2298.
Xiang C, Frietze KK, Bi Y, Li Y, Dal Pozzo V, Pal S, Alexander N, Baubet V, D'Acunto V, Mason CE et al..  2021.  RP58 Represses Transcriptional Programs Linked to Nonneuronal Cell Identity and Glioblastoma Subtypes in Developing Neurons.. Mol Cell Biol. 41(7):e0052620.